Read More
Newsletter Signup | Join Community | Cancer Types
Reversible BTK inhibitors promising in CLL. May represent new treatment options for individuals who develop resistance.
MedMaven
Apr 9, 2020
Connect with Others at Top Cancer Centers - Second Opinion Options...
TraceyS
Sep 19, 2019
Signs, symptoms, diagnosis and treatment of acute and chronic myeloid and lymphoid leukemias.
Cancer Connect
Sep 7, 2019
Brukinsa is a novel BTK inhibitor with encouraging anti-cancer activity in the management of CLL/SLL.
Jul 2, 2020
Zanubrutinib, obinutuzumab, venetoclax (BOVen) promising new treatment for Chronic Lymphocytic Leukemia and lymphomas.
Sustained progression free and overall survival benefits with Venclexta combined with Rituxan or Imbruvica.
Jun 30, 2020
FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia
Jun 16, 2020
Gleevec® for CML: Long-lasting Anticancer Responses Confirmed
Mar 13, 2020
Iclusig (ponatinib) is an effective treatment for CML.
Mar 6, 2020
Oct 28, 2018
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.
